Single-Step Blood Cell Staining Composition for Rapid Differentiation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current blood cell staining techniques require multiple steps and significant time, leading to inefficiencies in automated analysis systems, and struggle with even staining and differentiation of cell types like immature granulocytes.

Innovation Solution

A particle contrast agent composition comprising Basic Fuchsin, Brilliant Cresyl Blue, Azure B, Crystal Violet, and New Methylene Blue, combined with permeabilizing and fixing agents, is used to stain blood samples in a single-step process, suitable for automated flow cytometry systems.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If traditional multi-step staining process is used, then cell structure preservation and staining quality are improved, but processing time and system complexity increase

Engineering Contradiction:
Improvestaining qualityVSAvoidprocessing time
Core Design Contradiction:
Manufacturing precisionVSLoss of time

Solution Approach 1:

The patent combines multiple staining agents (Wright's stain components including methylene blue, eosin, and other dyes) into a single composite staining solution. This merging of multiple staining steps into one simultaneous application reduces processing time while maintaining the differential staining quality needed to distinguish various blood cell types and their granules

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The single staining composition serves multiple functions simultaneously: it stains different cell types (neutrophils, eosinophils, basophils, lymphocytes, monocytes), differentiates granule types (specific and nonspecific granules), and preserves cell morphology all in one step, replacing the need for multiple sequential staining operations

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Manufacturing precision

If traditional multi-step staining process is used, then staining quality is improved, but device complexity and operation difficulty increase

Engineering Contradiction:
Improvestaining qualityVSAvoidprocess complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent merges multiple separate staining solutions and application steps into a single composite staining composition and single application step. This eliminates the complexity of managing multiple reagents, timing sequences, and transfer operations while maintaining comprehensive staining capability for all blood cell types

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The universal staining composition performs all necessary staining functions in one application, making the process easier to operate and reducing the complexity of the staining system while achieving differential staining of all major blood cell types and their granules

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Productivity

If rapid staining is performed, then processing speed is improved, but staining evenness and cell differentiation capability deteriorate

Engineering Contradiction:
Improveprocessing speedVSAvoidstaining evenness
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent optimizes the chemical parameters of the staining composition, including pH, ionic strength, and dye concentrations, to enable rapid penetration and binding. The composition is formulated with specific ratios of acidic and basic dyes that allow quick differential staining while maintaining even color distribution across all cell types within seconds

Inventive Principle:
Principle #35Parameter changes

4Productivity

If sample volume is reduced for automated systems, then system efficiency is improved, but staining completeness and cell differentiation capability worsen

Engineering Contradiction:
Improvesystem efficiencyVSAvoidstaining completeness
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The staining composition is formulated with enhanced solubility and stability parameters that allow effective staining in reduced sample volumes. The optimized dye concentrations and buffer composition ensure complete cell penetration and granule differentiation even when working with the small sample volumes typical of automated hematology analyzers

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The composition achieves rapid and even staining of blood cells, allowing for efficient differentiation and sub-categorization of cell types within 90 seconds, enhancing the speed and accuracy of automated analysis.

Implementation Method 1

The particle contrast agent composition can include: a first staining agent, Basic Fuchsin; a second staining agent, at least one of Brilliant Cresyl Blue, Azure B, Crystal Violet and New Methylene Blue

Methodology Applied
Scientific EffectAdsorption: Adsorption

Implementation Method 2

a permeabilizing agent in an amount effective to permeabilize the cell membrane of the white blood cells

Methodology Applied
Scientific EffectSolvation: Solvation

Implementation Method 3

a fixing agent in an amount effective to fix the white blood cells

Methodology Applied
Scientific EffectChemical Bonding: Chemical Bonding

Data Source

PatentUS12517018B2Method and composition for staining and sample processing
Publication Date: 2026.01.06 BECKMAN COULTER INC
  • US12517018B2 patent drawing
  • US12517018B2 patent drawing
  • US12517018B2 patent drawing

AI summary

The present disclosure relates to a staining methodology employing a particle contrast agent composition. The compositions described herein are capable of rapidly staining cells in a single step. The particle contrast agent composition can be comprised of a combination of one or more particle contrast agents, one or more permeabilizing agents, and one or more fixing agents. The particle contrast agent composition can include Basic Fuchsin; at least one of Brilliant Cresyl Blue, Azure B, Crystal Violet and New Methylene Blue; one or more permeabilizing agents; and Gluteraldehyde.